For nine weeks, participants tracked their drinking habits and cravings, followed by another lab session where they consumed alcohol. Key findings: Nearly 40% of the semaglutide group reported no ...

The other half got sham injections. For nine weeks, everyone kept track of their drinking habits and their desire for alcohol. A lab visit with their favorite alcohol was repeated at the end of ...